Profile of antigen-specific antibody response detectable by Western blot in relation to diagnostic criteria for human immunodeficiency virus type-1 (HIV-1) infection

Clinical and Diagnostic Virology

Volumn 7, Issue 1, 1996, Pages 35-42

  Chattopadhya, D ^a   Aggarwal, R K ^a   Kumari, S ^a,b  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^b SEARO   (India)

Author keywords

Diagnostic criteria; Human immunodeficiency virus type 1; Western blot

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS DETECTION; WORLD HEALTH ORGANIZATION;

BLOTTING, WESTERN; FOLLOW-UP STUDIES; HIV ANTIBODIES; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; RISK FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LIA; UNIDENTIFIED RETROVIRUS;

EID: 0029853625     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(96)00251-6     Document Type: Article

References (28)

1. Allain, J.P., Laurian, Y., Einstein, M.H. et al. (1991) Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance. Blood 77, 1118-1123.
2. Carbadilla, C.D., Groopman, J.E., Lanigan, J., Renz, M., Lasky, L.A. and Capon, D. (1986) Serodiagnosis of antibodies to the human AIDS retrovirus with a bacterially synthesized env polypeptide. Biotechnology 4, 128-133.
3. Centers for Disease Control (1989) Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type-1 infections. MMWR 38 (Suppl. 7), 1-6.
4. Center for Infectious Diseases (1990) Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type-1 infections. Arch. Dermatol. 126, 19-21.
5. Chattopadhya, D., Riley, L. and Kumari, S. (1991) Behavioral risk factors for acquisition of human immunodeficiency virus infection among professional blood donors and their knowledge concerning acquired immunodeficiency syndrome in Delhi. Bull. WHO 69, 319-323.
6. Chattopadhya, D., Kumari S., Chatterjee, R. and Verghese, T. (1991) Limited evidence of human immunodeficiency virus type-2 infection in sera of blood donors showing reactive ELISA but negative or indeterminant results for HIV-1 infection. J. Commun. Dis. 23, 206-207.
7. Chattopadhya, D., Aggarwal, R., Sen, S. and Verghese, T. (1996) Lack of evidence of HIV-2 infection among multi-transfused thalassemic children in the city of New Delhi (Letter to the editor). J. Trop. Pediatr. 46, 45.
8. Constantine, N.T. (1993) Serological tests for retroviruses: approaching the decade of revolution. AIDS 7, 1-13.
9. De Cock, K.M., Porter, A., Kouadio, J. et al. (1991) Cross reactivity on Western blots in HIV-1 and HIV-2 infections. AIDS 5, 859-863.
10. Franchini, G., Robert-Guroff, M., Aldovinin, A., Kan, N.C. and Wong-Staal, F. (1987) Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood 69, 437-441.
11. Fransen, K., Pollet, D.E., Peters, M. et al. (1991) Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2. Eur. J. Clin. Microbiol. Infect. Dis. 10, 939-946.
12. Gelderblom, H.R., Hausmann, E.H.S., Ozel, M., Pauli, G. and Kock, M.A. (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156, 171-176.
13. Kitchen, L., Malone, G., Orgad, S. et al. (1986) Viral envelope protein of HTLV-III is the major target antigen for antibodies in haemophiliac patients. J. Infect. Dis. 153, 788-790.
14. Kreis, T.E. and Lodish H.F. (1986) Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell 46, 929-937.
15. McDougal, J.S., Kennedy, M.S., Nicholson, J.K.A. et al. (1987) Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titre and isotype to clinical status, severity of immunodeficiency and disease progression. J. Clin. Invest. 80, 316-321.
16. McHugh, T.M., Stites, D.P., Busch, M.P., Krowka, J.F., Stricker, R.B. and Hollander, H. (1988) Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24 and HIV-containing immune complexes in HIV infected patients. J. Infect. Dis. 158, 1088-1091.
17. Ng, V.L., Chiang, C.S., DeBouck, C. et al. (1989) Reliable confirmation of antibodies to human immunodeficiency virus type-1 (HIV-1) with an enzyme linked immunoabsorbent assay using recombinant antigens derived from HIV-1 gag, pol and env genes. J. Clin. Microbiol. 27, 977-982.
18. Nishanian, P., Huskins, K.R., Stehn, S., Detels, R. and Fahey, J.L. (1990) A simple method for improved assay demonstration that HIV p24 antigen is present as immune complexes in most sera from HIV infected individuals. J. Infect. Dis. 162, 21-28.
19. Pan, L.Z., Mayer, C.C. and Levy, J.A. (1987) Patterns of antibody response in individual infected with human immunodeficiency virus. J. Infect. Dis. 155, 626-631.
20. Pinter, A., Honnen, W.J., Tilley, S.A. et al. (1989) Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63, 2674-2679.
21. Pollet, D.E., Saman, E.L., Peeters, D.G. et al. (1991) Confirmation and differentiation of antibodies to human immunodeficiency virus I and II, using a strip based assay including recombinant antigens and synthetic peptides. Clin. Chem. 37, 1700-1707.
22. Schneider, J., Kaaden, O., Copeland, T.D., Oroszlan, S. and Hunsmann, G. (1986) Shedding and interspecies type seroreactivity of the envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 33, 449-462.
23. Truett, M.A., Chien, D.Y., Calarco, T.L. et al. (1989) Recombinant immunoblot assay for the detection of antibodies to HIV. In: K. Luciw and P. Steimer (Eds.), HIV Detection by Genetic Engineering Methods. Marcel Dekker, New York, pp. 121-141.
24. Wang, J.J.G., Steel, S., Wismewolski, R. and Wang, C.Y. (1986) Detection of antibodies to humans T-lymphotrophic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc. Natl. Acad. Sci. USA 83, 6159-6163.
25. WHO (1990) Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/ HTLV-II. WHO Weekly Epidem. Rec. 37, 281-283.
26. Wilber, J.C. (1994) HIV testing: methodology. In: P.T. Cohen, M.A. Sante and P.A. Volberding (Eds.), The AIDS Knowledge Base. Little Brown, London, 2nd edn., pp. 2.1-2.7.
27. Willey, R.L., Bonafacino, J.S., Potts, B.J., Martin M.A. and Klausner, R.D. (1988) Biosynthesis, cleavage and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85, 9580-9584.
28. Zolla-Pazner, S., Gorney, M.K. and Honnen, W.J. (1989) Reinterpretation of HIV Western blot patterns. N. Engl. J. Med. 320, 1280-1281.